LIVE
NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

SMSPHARMA

NSEBSE
SMS Pharmaceuticals Limited
Healthcare· Pharmaceuticals & Biotechnology· INE812G01025· Scrip: 532815
ENहिन्दीગુજરાતીमराठी
₹418.40
▼ 10.60 (-2.47%)
20/4/2026, 10:29:40 pm
NSE
₹418.40
▼ 10.60
-2.47%
BSE
₹407.80
▲ 9.00
+0.00%
21427032738444005-0206-2708-2510-2312-1902-1804-2704-30
244 trading days · 1Y period
TODAY
Open428.95
High433.50
Low415.10
Prev Close429.00
Volume9.37Cr
Value₹0.3Cr
L: 415.10H: 433.50
52 WEEK
Low₹207.70
High₹447.80
88% of 52W range
Info
Face Value₹1
Listed2007-02-28
ISININE812G01025
SeriesB
BSE Scrip532815

Key Metrics

1D
-1.00%
1W
-2.30%
1M
+2.75%
3M
+31.12%
6M
+38.55%
Valuation
Mkt Cap₹3643 Cr
Growth (QoQ)
Revenue-11.89%
PAT+29.38%
EPS+27.22%
Profitability
Dividend
Yield0.10%
Growth+0.00%
TTM Revenue
₹780 Cr
TTM EBITDA
₹119 Cr
TTM PAT
₹66 Cr
TTM EPS
₹7.81
Rev/Share
₹83.3

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr61 Cr123 Cr184 Cr246 Cr22-1223-0323-0923-1224-0324-0624-0924-12₹0.4₹0.7₹1.4₹1.4₹2.0₹1.9₹1.7₹2.1
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31173 Cr153 Cr31 Cr22 Cr18 Cr₹2.15
2024-09-30197 Cr179 Cr28 Cr20 Cr14 Cr₹1.69
2024-06-30164 Cr144 Cr30 Cr22 Cr16 Cr₹1.93
2024-03-31246 Cr226 Cr30 Cr22 Cr17 Cr₹2.04
2023-12-31161 Cr146 Cr25 Cr17 Cr11 Cr₹1.36
2023-09-30167 Cr152 Cr23 Cr15 Cr12 Cr₹1.39
2023-03-31149 Cr140 Cr19 Cr11 Cr6 Cr₹0.73
2022-12-31149 Cr144 Cr15 Cr7 Cr4 Cr₹0.44

Shareholding Pattern

CURRENT — 2026-03-31
68.1%PROMOTER
Promoter68.1%
FII0.3%
DII3.0%
Public31.9%
PROMOTER HOLDING TREND
64.7%24-1266.3%25-0366.3%25-0366.3%25-0668.1%25-0968.1%25-1268.1%26-03

Corporate Actions

Ex-DateTypePurpose
2025-09-22DividendDividend - Re 0.40 Per Share
2024-09-23OtherAnnual General Meeting
2024-09-23DividendDividend - Rs 0.40 Per Share
2023-09-22DividendDividend - Re 0.30 Per Share
2023-09-22OtherAnnual General Meeting
2022-09-22OtherAnnual General Meeting
2022-09-22DividendDividend - Re 0.30 Per Share
2021-09-22Dividend Annual General Meeting/ Dividend Rs 0.30 Per Share
2020-09-17Other Annual General Meeting
2020-03-26Dividend Interim Dividend - Rs 0.25 Per Share
2019-09-19Dividend Dividend - Rs 0.25 Per Share
2018-09-11Dividend Annual General Meeting/Dividend Re 0.25 Per Share
2017-09-20Dividend Annual General Meeting/Dividend - Rs 0.20 Per Share
2017-06-22Other Scheme Of Arrangement
2016-09-22Dividend Dividend Re 0.20 Per Share
2015-12-17Split Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share
2015-09-22Dividend Annual General Meeting/ Dividend - Rs 2/- Per Share
2014-09-23DividendAnnual General Meeting And Dividend Rs.2/- Per Share
2013-09-23DividendAnnual General Meeting / Dividend - Rs 2 Per Share
2012-09-20OtherAnnual General Meeting

Earnings Transcripts

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
10 Nov 2025NSE19K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
10 Aug 2025NSE12K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
31 May 2025NSE15K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
12 Feb 2025NSE13K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
9 Nov 2023NSE33K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
9 Aug 2023NSE29K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
25 May 2023NSE30K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...
23 Nov 2022NSE44K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
14 Nov 2022NSE32K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...
23 Aug 2022NSE38K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
13 Aug 2022NSE29K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...
9 Jun 2022NSE44K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation
2 Jun 2022NSE30K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange regarding 'Re-schedule of Conference Call for ...
18 Feb 2022NSE1K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of conference call'.
11 Feb 2022NSE2K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange regarding 'Press release and investor presenta...
10 Feb 2022NSE39K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange regarding 'Earnings call Transcript Q2 FY22'.
23 Nov 2021NSE65K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange regarding 'Revised intimation of conference ca...
16 Nov 2021NSE2K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Conference call Ref: ...
16 Nov 2021NSE2K chars
Read →
SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of conference callRef: R...
16 Nov 2021NSE2K chars
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-30414.00414.45397.25403.702.05L
2026-04-29392.00415.00391.10410.104.16L
2026-04-28399.65403.90387.00390.252.12L
2026-04-27397.20405.90395.00399.651.51L
2026-04-24418.50419.00392.20396.703.66L
2026-04-23420.25432.60413.00415.554.35L
2026-04-22405.10423.00405.10420.251.99L
2026-04-21423.00424.85407.00408.102.12L
2026-04-20428.95433.50415.10417.701.89L
2026-04-17425.80434.00425.10429.001.61L
2026-04-16439.85446.00421.40424.404.00L
2026-04-15425.00447.80424.00438.306.17L
2026-04-13410.00422.50397.60416.852.57L
2026-04-10420.00429.95414.10418.404.15L
2026-04-09400.00419.90395.30415.005.11L
2026-04-08405.90405.90393.10399.202.17L
2026-04-07386.00396.70383.05390.052.14L
2026-04-02385.00391.15370.25388.253.84L
2026-04-01393.80404.90382.05392.753.35L
2026-03-27398.95412.05385.00386.153.37L
2026-03-25395.50413.80394.00404.556.53L
2026-03-24376.65399.60372.60395.155.22L
2026-03-20367.25394.25367.25385.054.92L
2026-03-19376.55379.00362.60366.101.72L
2026-03-18375.10387.20373.90382.252.24L
2026-03-17365.80378.80365.80372.702.17L
2026-03-16370.00379.90356.20366.154.23L
2026-03-13400.00403.00366.25368.757.58L
2026-03-12410.00419.90401.10405.203.80L
2026-03-11422.00433.90411.05413.407.74L

Frequently Asked Questions

About

SMS Pharmaceuticals Limited, incorporated in 1987 and headquartered in Hyderabad, India, is an integrated pharmaceutical company specializing in Active Pharmaceutical Ingredients (API) and complex intermediates across therapeutic categories such as anti-ulcer, anti-fungal, anti-migraine, anti-viral, anti-diabetic, and anti-retroviral. The company operates multiple manufacturing facilities and research centers, employing over 1,000 professionals, and holds a global leadership position in more than 10 therapeutic products.

BOARD OF DIRECTORS
Vamsi Krishna Potluri
Whole-time Director
Shravan Kudaravalli
Independent Director
Srinivas Sarvepalli
Independent Director